BPA Call 36C26125A0015-36C26125N0317

Award Date 2/1/25
Potential Completion Date 1/31/26
Potential Value $308K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Emigration Canyon, UT 84108, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) call contract to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of blood culture and antimicrobial susceptibility testing (AST)/identification (ID) reagents. The $122,888.69 firm-fixed-price contract has an ultimate completion date of October 31, 2024 and does not involve any set-aside designation. Biomerieux, through its Biomerieux, Inc. division, will supply the VA's...
The U.S. Department of Veterans Affairs (VA) has awarded a Firm-Fixed-Price Blanket Purchase Agreement (BPA) Call to Biomerieux Inc., a global leader in in vitro diagnostics, with a ceiling value of $45,935.20. The contract is for DO LAB CPT AO ID SUSCEPTIBILITY - FARGO and does not have a set-aside designation. Biomerieux, through its Biomerieux, Inc. Division, will provide specialized diagnostic equipment, reagents, and services to support infectious disease testing and pathogen detection...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call to Biomerieux Inc., a global leader in in vitro diagnostics, for $38,390.70. This contract is for the provision of PCR testing services and products, including Biomerieux's proprietary Vitek, BioFire, and VIDAS systems for automated microbial identification, antibiotic susceptibility testing, and molecular diagnostics. The contract has a period of...
The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) call order to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of reagents and E-test strips. The contract has a ceiling value of $13,000.00 and a performance period ending on September 30, 2025. This contract is a firm fixed-price arrangement and does not involve any set-aside designations. Biomerieux Inc., through its Biomerieux, Inc. division, is the prime contractor for this...
The U.S. Department of Veterans Affairs (VA) awarded a firm-fixed-price delivery order contract worth $29,559.00 to Biomerieux Inc. for automated blood culture testing equipment and supplies. The contract has a period of performance through June 3, 2025. Biomerieux Inc., a global leader in in vitro diagnostics, is providing its proprietary VITEK, BioFire, and VIDAS platforms and associated consumable products to support infectious disease testing and pathogen detection across VA healthcare...
The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) call to Biomerieux Inc., a division of Biomerieux, Inc., for blood culture testing supplies and services. The contract has a ceiling value of $52,469.00 and runs through March 14, 2024. Biomerieux is a global leader in in vitro diagnostics and holds multiple federal contracts with the VA, Department of Defense, Department of Agriculture, and Department of Health and Human Services to provide its specialized...
The Department of Veterans Affairs Veterans Health Administration has awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., Biomerieux, Inc. Division, a foreign-owned for-profit manufacturer of in vitro diagnostic equipment, reagents, and supplies. The $30,012.76 BPA Call contract is for the provision of automated microbiological identification and susceptibility testing systems, including the company's Vitek, BioFire, and VIDAS product lines, to support infectious disease testing and...
The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the procurement of automated microbiological blood culture testing equipment, reagents, and supplies. The contract has a ceiling value of $105,849.45 and a period of performance through September 30, 2025. This BPA call contract is a firm-fixed-price arrangement and does not have a set-aside designation. Biomerieux Inc., through its...
The U.S. Department of Veterans Affairs (VA) has awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call to Biomerieux Inc. for Blood Culture Testing services. The contract, valued at $39,140.00, has an ultimate completion date of March 14, 2024. Biomerieux Inc., a global leader in in vitro diagnostics, will provide the VA's healthcare facilities with its specialized diagnostic equipment, reagents, and supplies through this award. The contract is not set-aside and is part of...
The Department of Veterans Affairs Veterans Health Administration has awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call to Biomerieux Inc., a global leader in in vitro diagnostics, to provide its proprietary VIDAS microbiology testing systems, reagents, and consumables. This $39,007.73 order has a completion date of March 31, 2024 and is being issued under a larger VA indefinite delivery contract vehicle worth over $194 million for in vitro diagnostics across the agency's...
  • 36C26125A0015
    Blanket Purchase Agreement
  • 36C26125A0015-36C26125N0317
    BPA Call

The U.S. Department of Veterans Affairs (VA) has awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call order valued at $308,070.88 to Biomerieux Inc., a global leader in in vitro diagnostics. The contract is for the supply of Biomerieux's VAPA (Vitek Automated Phenotypic Assay) products, which are used for microbial identification and antibiotic susceptibility testing. This order is part of a larger BPA held by Biomerieux with the VA, which allows the agency to efficiently access the company's proprietary diagnostic platforms and consumables. The contract does not have a set-aside designation, as Biomerieux is often the sole provider of its specialized technologies. The award supports the VA's healthcare operations and its ability to rapidly detect and identify pathogens, which is essential for serving the needs of the veteran population.

Generated 2/8/25, 9:12 AM